Development of an EORTC questionnaire for individuals at risk for a Hereditary Cancer Predisposition Syndrome: the EORTC QLQ-HCPSxx (Phase 3)

Van Hemelrijck, Mieke (Primary Investigator)

Comprehensive Cancer Centre

Project: Research

Acronym	EORTC HCPS
Status	Finished
Effective start/end date	1/01/2023 → 31/12/2024

Collaborative partners

King's College London
Medical University of Innsbruck (lead)

Funding

EORTC European Organisation for Research and Treatment of Cancer: £14,532.17